← Evidence map

TrialJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2025

Phase II Randomized Study of Maintenance Atezolizumab Versus Atezolizumab Plus Talazoparib in Patients With SLFN11 Positive Extensive-Stage SCLC: S1929.

Nagla Abdel Karim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

49 papers cite it

2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 39505259